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Abstract
Background: First described in humans in 1964, reports of co-infections with dengue (DENV) and chikungunya (CHIKV)
viruses are increasing, particularly after the emergence of chikungunya (CHIK) in the Indian Ocean in 2005–2006 due to a
new variant highly transmitted by Aedes albopictus. In this geographic area, a dengue (DEN) outbreak transmitted by Ae.
albopictus took place shortly before the emergence of CHIK and co-infections were reported in patients. A co-infection in
humans can occur following the bite of two mosquitoes infected with one virus or to the bite of a mosquito infected with
two viruses. Co-infections in mosquitoes have never been demonstrated in the field or in the laboratory. Thus, we question
about the ability of a mosquito to deliver infectious particles of two different viruses through the female saliva.
Methodology/Principal Findings: We orally exposed Ae. albopictus from La Reunion Island with DENV-1 and CHIKV isolated
respectively during the 2004–2005 and the 2005–2006 outbreaks on this same island. We were able to show that Ae.
albopictus could disseminate both viruses and deliver both infectious viral particles concomitantly in its saliva. We also
succeeded in inducing a secondary infection with CHIKV in mosquitoes previously inoculated with DENV-1.
Conclusions/Significance: In this study, we underline the ability of Ae. albopictus to be orally co-infected with two different
arboviruses and furthermore, its capacity to deliver concomitantly infectious particles of CHIKV and DENV in saliva. This
finding is of particular concern as Ae. albopictus is still expanding its geographical range in the tropical as well as in the
temperate regions. Further studies are needed to try to elucidate the molecular/cellular basis of this phenomenon.
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Introduction
Dengue (DEN) and chikungunya (CHIK) are two mosquito-
borne viral infections transmitted by mosquitoes of the genus Aedes.
Dengue viruses (DENV-1, -2, -3, -4) belonging to the Flaviviridae
family, Flavivirus genus [1] are of primarily concern as they are
responsible of the most important arboviral disease widely
distributed in the tropical world [2]. Dengue infection may be
unapparent or induce an undifferentiated febrile illness, a classic
dengue fever (DF), or a dengue hemorrhagic fever (DHF). The
highest prevalence of DEN is observed in South-East Asia and
South Americas with approximately 50–100 million cases and 25
000 deaths per year [3]. The transmission is mainly ensured by the
highly anthropophilic Aedes aegypti in urban areas [4]. However,
Aedes albopictus may act as a secondary vector in rural areas and
even as the main vector when Ae. aegypti is not present or too scarce
as observed in some localities in China, Japan, Hawaii, and
Seychelles [5]. Ae. albopictus was indeed the only vector in the
recent dengue outbreaks observed in the Indian Ocean on La
Reunion Island [6] and Madagascar [7].
Chikungunya virus (CHIKV), first isolated in Tanzania in 1953
[8], belongs to the Togaviridae family, Alphavirus genus [9] and is
endemic to Africa, India and South-East Asia. In Africa, the virus
is maintained within a sylvatic cycle with wild mosquitoes (Aedes
furcifer, Aedes luteocephalus, Aedes taylori, Aedes africanus) feeding
preferentially on primates [10,11]. In Asia, CHIKV is mainly
transmitted within an urban cycle in an inter-human transmission
achieved essentially by the human-biting Ae. aegypti and the less
anthropophilic Ae. albopictus, which prefers suburban and rural
areas where it colonizes both artificial and natural containers
[12,13]. CHIKV mainly induces high fever and severe arthralgia,
and had limited impacts on public health before its emergence in
the Indian Ocean in 2005. This major epidemic started in the
Comoro Islands in January 2005 then spread rapidly to the other
islands of the region, Mayotte, Seychelles, La Reunion and
Mauritius [14]. In April 2006, one third of the population in La
Reunion Island had been in contact with the virus [15].
Surprisingly, the vector in this epidemic was not Ae. aegypti, only
present as residual populations on the island, but Ae. albopictus
[16–18]. This latter species was proved to be a very efficient vector
of a mutated strain CHIKV harboring a switch from an alanine to
a valine in the E1 glycoprotein, mutation that appeared in the
course of the outbreak and was then selected as a major epidemic
genotype [19,14]. CHIK outbreaks spread rapidly and caused
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India, where outbreaks had been absent for 32 years [20,21]. One
consequence was an increasing overlapping in the distribution of
the two arboviral diseases, DEN and CHIK leading to the
detection of a higher number of co-infections in humans.
Co-infection by DENV and CHIKV in patients has been known
for a long time. First described in 1964 in South India [22], it has
been more frequently reported since the re-emergence of CHIK:
Sri-Lanka [23], India [24,25], Malaysia [26] where the main vector
involved is Ae. aegypti and in Gabon [27], Madagascar [7] and La
Reunion Island [28] where viral transmission is achieved by Ae.
albopictus. On La Reunion Island, the CHIK outbreak was preceded
by a small outbreak due to DENV-1 with 228 cases reported
between March and July 2004 [6]. Despite the limited impact of the
DEN outbreak, in January 2006, suspected cases of co-infection
DENV-CHIKV in patients were reported [28] and the same
phenomenon was also observed in Madagascar in January 2006 [7].
Dual arboviral infections in humans can occur following the bite
of two mosquitoes, each infected by one virus, or the bite of one
mosquito infected by the two viruses. If isolations of either virus
from mosquitoes collected in the course of an epidemic have been
already noticed, to our knowledge, doubly infected mosquitoes
have never been described. A recent study even concluded on the
failure to prove co-infection of Ae. aegypti by these two viruses [29].
Here, we orally infected in a single blood-meal, Ae. albopictus from
La Reunion Island with autochthonous viral strains isolated during
the 2004–2005 outbreak of DEN-1 and the 2005–2006 CHIK
outbreak. Dissemination of both viruses within the vector was
checked by immunofluorescence assay on female head squashes.
Furthermore, saliva was collected from each female to check their
ability to deliver simultaneously both DENV and CHIKV
infectious particles. Additionally, we performed secondary infec-
tions by inoculating first DENV-1 then providing CHIKV in an
infectious blood-meal.
Methods
Ethics statement
All experiments on live vertebrates were performed in
compliance with French and European regulation and according
to the Institut Pasteur guidelines for laboratory animal husbandry
and care.
Mosquitoes
Ae. albopictus Providence (ALPROV) were collected as eggs in
2006 on La Reunion Island and provided by the DRASS
(Direction Re ´gionale des Affaires Sanitaires et Sociales). The F5
or F6 generation was used for experimental infections. Colonies
were maintained at 2861uC with a light:dark cycle of 16 h:8 h
and a 80% relative humidity. Larvae were reared in pans
containing 1 yeast tablet in 1 liter of tap water. Adults were
provided with 10% sucrose solution ad libitum and fed three times a
week on anaesthetized mice.
Virus
The CHIKV 06.21 isolated in November 2005 from a new-
born male from La Reunion Island presenting meningo-enceph-
alitis symptoms was used for all experiments. This strain harbored
the A-.V mutation at the position 226 in the E1 glycoprotein (E1-
226V) [14]. Viral stock used was a third passage on Ae. albopictus
C6/36 [30] stored at 280uC in aliquots. Procedure for C6/36 cell
infections and passages are described elsewhere [19].
The DENV-1 185/04 was isolated in May 2004 from the
plasma of a patient in La Reunion Island. The strain belonged to
the Brazil group of the Pacific genotype which was the main
genotype isolated during the outbreak (GenBank: DQ285558.1).
The virus was provided as a second passage on C6/36 cells.
DENV-1 production on mosquito cell cultures being insufficient to
allow mosquito oral infections, the virus stock was produced by
inoculating intra-thoracically mosquitoes with the viral strain [31].
Inoculated mosquitoes were incubated 10 days at 28uC and their
infectious status checked by indirect immunofluorescent assay
(IFA) on head squashes [32]. Bodies were then pooled and
triturated in heated (56uC for 30 min) FCS (Fetal Calf Serum).
The supernatant fluid recovered after low speed centrifugation was
used as a source of virus in mosquito blood-meals.
Both viruses were provided by the French National Reference
Center for Arboviruses at the Institut Pasteur which had obtained
the verbal consent from patients or parent’s patients who provided
blood sera.
Intrathoracic inoculation of mosquitoes
Adult females were inoculated using the protocol described by
Rosen and Gubler [31], each mosquito receiving 0.17 mL (i.e.
10
2.8 PFU/mL) of the DENV-1 strain.
Oral infection of mosquitoes
Infection assays were performed with 7 day-old females which
were allowed to feed for 15 min through a chicken skin membrane
covering the base of a glass feeder containing the blood-virus
mixture maintained at 37uC. The infectious blood-meal was
composed of a virus suspension diluted (1:3) in washed rabbit
erythrocytes isolated from arterial blood collected 24 h before the
infectious blood-meal [33]. A phagostimulant, ATP, was added at
a final concentration of 5610
3 M. Fully engorged females were
transferred to small cardboard containers and maintained with
10% sucrose at 2861uC for 14 days. Viral suspension provided in
the blood-meal contained one or two viruses. For the secondary
infection experiment, the blood-meal with CHIKV yielding
10
6 FFU (foci forming unit)/mL was provided 7 or 13 days after
inoculation with DENV-1. As control, females were inoculated
with DENV-1 alone or orally infected with CHIKV alone. For the
two trials where both viruses were provided by oral route, titers of
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Dengue (DEN) and chikungunya (CHIK) are two mosquito
borne infections transmitted by Aedes mosquitoes in the
tropical world. Ae. albopictus has been shown to efficiently
transmit the new variant of CHIK virus (CHIKV) that
emerged in the Indian Ocean region in 2005. At the same
time, this vector is able to sustain outbreaks due to DEN
virus (DENV). Since this CHIK emergence, co-infections
DENV-CHIKV in humans have been regularly reported. This
phenomenon, known for a long time, may be due to two
consecutive bites from two mosquitoes infected by one
virus or by the bite of a mosquito infected by both viruses.
We used two viral strains isolated in La Reunion Island,
DENV-1 in 2004 and CHIKV in 2005, and co-infected an
autochthonous strain of Ae. albopictus, testing experimen-
tally one of the possible ways to get co-infections in
humans. We were able to show the ability of Ae. albopictus
to replicate simultaneously both arboviruses and, further-
more, to deliver both infectious viral particles concomi-
tantly in their saliva. This finding is of particular interest
since Ae. albopictus is now widely distributed all around
the world and still expanding its geographical range.
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6 FFU/mL for CHIKV in
both trials and 10
4,5 FFU/mL for DENV-1 in the trial 1 and
10
5,9 FFU/mL for DENV-1 in the trial 2.
Saliva collection and virus detection/titration
At day 14 post-infection, females were chilled, and their wings
and legs removed, the stress inducing a forced salivation. Proboscis
was inserted into 1 mL micropipette (microcapsH, Drummond
Scientific Company, USA) filled with FCS. After 45 min, medium
containing the saliva was expelled under pressure into 1.5 mL
tubes containing Leibovitz L15 medium supplemented with 10%
FBS. To allow a specific detection of both viruses, each sample was
inoculated in two wells, one for the detection of CHIKV and one
for the detection of DENV-1. 20 mL of each sample were added to
monolayers of C6/36 cells in 24 wells plaque to detect infectious
particles by the foci forming technique using an immunoperox-
ydase assay. Cells were incubated 3 days for CHIKV and 5 days
for DENV-1 at 28uC under an overlay consisting of 50% of
Leibovitz L-15 medium supplemented with 10% FBS and 50% of
carboxyl methyl cellulose. Cells were then fixed with 3.6%
formaldehyde at room temperature (RT) for 20 min and a
immunoperoxydase assay staining was performed to detect foci.
After a first incubation of 4 min with PBS 0.1% Triton X-100
(Sigma) at RT, cells were incubated 20 min at 37uC with a mouse
ascitic fluid at a dilution of 1:1000 for CHIKV and 1:100 for
DENV-1 (both ascetic fluids were provided by the French
National Reference Center for Arbovirus at the Institut Pasteur).
After a wash in PBS 1X, cells were incubated at 37uC for 45 min
with peroxydase-conjugated goat anti-mouse IgG antibody (Pierce
biotechnology, Rockford, USA) at a 1:100 dilution in PBS 1X.
After final wash in PBS 1X, Fast 3,39 Diaminobenzidine (Sigma)
was used to reveal the staining and foci were counted. The titer of
infectious particles per saliva was expressed as FFU/mL (mean 6
standard deviation).
Female status analyzed by IFA
After salivation, females were tested for the presence of CHIKV
and DENV-1 by IFA on their head squashes [32]. CHIKV and
DENV-1 antigens were detected with the same mouse ascitic fluids
used for saliva titration. Head squashes being performed between
two slides, infection status of females fed with both viruses, could
be checked for both antigens by using one slide for each IFA.
Mosquitoes inoculated with CHIKV and DENV-1 were used as
positive controls, negative controls were inoculated with cell
culture media.
Results
Secondary infection with CHIKV of Ae. albopictus
previously inoculated with DENV-1
As shown on Table 1, only few females inoculated with DENV-
1 were willing to feed on an artificial blood-meal in the BSL-3
insectarium. When a blood-meal was proposed at day 7 post-
inoculation, eight females out of 106 fed and among them, three
survived until day 13 post-inoculation. By IFA on head squashes,
we found that all 3 females had disseminated both viruses. Besides,
when a blood-meal was offered at day 13 post-inoculation, eight
females out of 54 females fed and four survived until day 20 post-
inoculation. These four females had disseminated both viruses.
Control females inoculated or orally infected by only one virus
were all positive.
Oral co-infections
Females were exposed to both viruses in a same blood-meal and
disseminated infection rates were estimated at day 14 post-
infection (pi) (Table 2). In the trial 1, 71.6% of females have only
disseminated CHIKV, 0% only DENV-1, 18.6% both viruses and
9.8% did not disseminate any virus. In the trial 2, 30.8% of
females have only disseminated CHIKV, 7.7% only DENV-1,
50.8% both viruses and 10.7% did not disseminate any virus.
When providing a higher titer of DENV-1 in the blood-meal (trial
2), a higher proportion of females were co-infected with both
viruses.
For females having disseminated both viruses, saliva was
collected at day 14 pi and titrated. Relative transmission of the
two viruses are shown in Table 3. In the trial 1, out of 19 saliva, 4
contained simultaneously CHIKV and DENV-1, 4 only CHIKV,
3 only DENV-1 and 8 no virus. In the trial 2, out of 33 saliva, 9
presented concomitantly CHIKV and DENV-1, 8 only CHIKV, 2
only DENV-1 and 14 no virus. Mean titers, expressed as FFU per
saliva, and standard deviation are shown on Table 4.
Discussion
We report here the ability of Ae. albopictus from La Reunion
Island to replicate simultaneously autochthonous strains of
DENV-1 and CHIKV provided in the same blood-meal and to
deliver both infectious viral particles in their saliva. To our
knowledge, such co-infection has never been shown neither under
laboratory conditions nor in the field. Lastly, we succeeded in
inducing a secondary infection with CHIKV 7 or 13 days after a
first infection with DENV-1 virus.
CHIKV and DENV are both transmitted by Ae. aegypti and Ae.
albopictus, the former being considered the major vector and the
latter, the secondary vector. However Ae. albopictus is able to sustain
DEN outbreaks in the absence of Ae. aegypti [5]. Indeed, in the
Indian Ocean, Ae. albopictus was predominant in Seychelles and in
La Reunion Island where the species took part of DEN outbreaks
in 1976-77 [34,35] and in 2005 [6]. On La Reunion Island, Ae.
aegypti populations are scarce and do not exhibit a high
anthropophily [16,17] while Ae. albopictus has favored the
emergence of a new CHIKV strain harboring a substitution
(alanine R valine) at the position 226 of the E1 glycoprotein
during the 2005–2006 outbreak. This variant presents high levels
of replication in Ae. albopictus [19] and a short extrinsic incubation
Table 1. Superinfection with CHIKV of Aedes albopictus Providence previously inoculated with DENV-1.
at day 7 post-inoculation at day 13 post-inoculation
Engorged females
at day 7 pi (N)
Surviving females
at day 13 pi (N)
Co-infected females
at day 13 pi (N)
Engorged females
at day 13 pi (N)
Surviving females
at day 20 pi (N)
Co-infected females
at day 20 pi (N)
8 (106) 3 (8) 3 (3) 8 (54) 4 (8) 4 (4)
N, number of females tested.
doi:10.1371/journal.pntd.0000706.t001
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after infection [36]. Subsequent outbreaks due to the new CHIKV
variant were often related to transmission by Ae. albopictus
corroborating an adaptative mutation in response to a require-
ment for transmission by this species. Moreover, co-infections with
both DENV and CHIKV have been detected in some patients
from La Reunion Island [28] and Madagascar in 2006 [7].
Co-infections CHIKV-DENV in patients have been first
described in 1967 and since the emergence of CHIKV in the
Indian Ocean, reports of co-infections are increasing: in the Indian
Ocean, as mentioned above, but also in Sri-Lanka [23], Malaysia
[26], in India [24,25] where the main vector involved is Ae. aegypti
and in Gabon [27]. Except for the Americas still free of CHIK
infection, the geographic range of CHIK is now largely
overlapping that of DEN. Furthermore, the emergence of CHIK
outbreaks due to the new variant coincided with the recent
establishment of Ae. albopictus in Central Africa, in Cameroon
[37,38] and Gabon [39,40]. In 2007, patients with co-infections
DENV-CHIKV were indeed detected for the first time in Africa in
Gabon [27].
Co-infection of a mosquito vector by two different viruses can
occur by the way of two successive infectious blood-meals taken on
two different viremic hosts or by one blood-meal taken on a co-
infected host. We chose to mix both viruses in the same meal since
Ae. albopictus females from La Reunion Island were reluctant to
feed twice at 7 or 13 days interval on an infectious meal in the
BSL-3 conditions. If Ae. albopictus females can be readily fed on an
artificial meal in a BSL-3 laboratory it is very difficult to make
them take a second artificial meal in the same conditions after 1 or
2 weeks of incubation and even to make then take a first meal if
they have been kept more than 48 h in the depression conditions
of the BSL-3. Temperature and humidity were optimal, females
had the opportunity to lay their eggs if needed, were starved prior
blood-feeding as usual. Therefore, we were unable to offer viruses
in sequential meals and choose to test the possibility of a
superinfection by first injecting one virus (DENV-1) then offering
an infectious blood meal with the second virus (CHIKV) 7 or 13
days latter. Even then, we had very few individuals blood-fed but
could however detect replication and dissemination of both
viruses.
Ae. albopictus from La Reunion Island were already known to be
a very efficient vector for the new CHIKV variant and able to
sustain DEN outbreaks. We demonstrated that replication of both
viruses can take place simultaneously and vectors become able to
transmit the two viruses in a single bite. In Ae. albopictus, CHIKV
infectious particles can be found in saliva from two days after oral
infection [36] when this delay is much longer for DENV at least 10
days [41–42]. We performed the saliva analysis 14 days after
feeding the females on a co-infected blood-meal but were not able
to detect infectious viral particles in all saliva collected from
females presenting a disseminated infection of both viruses. As
CHIKV was not detected, when it should have been considering
its rapid excretion in saliva [36], females with negative saliva must
have been females unable to salivate using our technique [36] or
excreting a very small amount of infectious particles that we could
not detect due to the low sensitivity of the technique of viral
detection. It would be interesting to perform a kinetic study of
excretion of infectious particles from females exposed to one or
both viruses while controlling the presence of saliva in the collected
samples. We performed our study with Ae. albopictus from La
Reunion Island with two viral strains isolated in the same area
during the DENV-1 outbreak of 2005 and the CHIKV outbreak
of 2005–2006. This combination vector/virus fits well with the
natural context strengthening the findings of this work. Neverthe-
less, it seems difficult to infer to other epidemiological contexts as
shown by the failure of Rohani et al. [29] to prove co-infection of
Ae. aegypti by CHIKV and DENV. The mechanism of co-infection
in Ae. albopictus by two different arboviruses needs to be further
investigated and tested using additional trials with different viral
strains to determine if this phenomenon is an exception due to the
particularly well adapted partners or a quite common mechanism.
The still ongoing expansion of this species, particularly in Africa
where numerous arboviruses are transmitted, in of particular
concern and, if the co-infection was a quite usual phenomenon
Table 2. Disseminated infection rates (%) of Aedes albopictus
Providence 14 days after a blood-meal with both CHIKV and
DENV-1.
CHIKV DENV-1 CHIKV + DENV-1 Non-infected Total
Trial 1 71.6 0 18.6 9.8 102
Trial 2 30.8 7.7 50.8 10.7 65
Disseminated infection rates were estimated by IFA on head squashes. For
CHIKV, both trials used a blood-meal at a titer of 10
6 FFU/mL. For DENV-1, trial 1
corresponded to a blood-meal at a titer of 10
4.5 FFU/mL and trial 2 to a titer of
10
5.9 FFU/mL. Total corresponds to the total number of females tested.
doi:10.1371/journal.pntd.0000706.t002
Table 3. Relative transmission of the two viruses by dually
infected mosquitoes.
DENV-1
Trial 1 Trial 2
Yes No Yes No
CHIKV Yes 4 4 9 8
N o 38 21 4
Saliva from females having disseminated both viruses 14 days after an
infectious blood-meal was tested for the presence of both viruses. For CHIKV,
both trials used a blood-meal at a titer of 10
6 FFU/mL. For DENV-1, trial 1
corresponded to a blood-meal at a titer of 10
4.5 FFU/mL and trial 2 to a titer of
10
5.9 FFU/mL.
doi:10.1371/journal.pntd.0000706.t003
Table 4. Mean numbers 6 standard deviations of infectious
viral particles in saliva of Aedes albopictus Providence co-
infected with CHIKV and DENV-1.
Trial 1 (N) Trial 2 (N)
Saliva with both viruses
detected
CHIKV 16610 (4) 44675 (9)
DENV-1 746134 (4) 46666 (9)
Saliva with only one virus
detected
CHIKV 461 (4) 45664 (8)
DENV-1 461 (3) 1760( 2 )
The saliva of females detected positive for both viruses by IFA on head
squashes, 14 days after an infectious blood-meal were titrated. Titers were
expressed in FFU (foci forming units). For CHIKV, both trials used a blood-meal
at a titer of 10
6 FFU/mL. For DENV-1, trial 1 corresponded to a blood-meal at a
titer of 10
4.5 FFU/mL and trial 2 to a titer of 10
5.9 FFU/mL. N refers to the total
number of females tested.
doi:10.1371/journal.pntd.0000706.t004
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that superinfection is possible in mosquitoes as well as in cells
infected with heterologous viruses (i.e., different genus) and not
with homologous ones [43–47]. Little is known about the
molecular and cellular basis of co-infection which should be
explored.
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